52 related articles for article (PubMed ID: 20517336)
1. Unraveling family ties in Hodgkin lymphoma.
Fox LC
Blood; 2023 Mar; 141(11):1240-1241. PubMed ID: 36929435
[No Abstract] [Full Text] [Related]
2. Johnston RL, Mottok A, Chan FC, et al. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. Blood. 2022;139(6):889-893.
Blood; 2023 Mar; 141(12):1495. PubMed ID: 36951881
[No Abstract] [Full Text] [Related]
3. Progress Toward Cardiac Risk Reduction With the Evolution of Pediatric Hodgkin Lymphoma Therapy.
Leger KJ; Narayan HK
JAMA Netw Open; 2024 Jan; 7(1):e2350999. PubMed ID: 38241051
[No Abstract] [Full Text] [Related]
4. The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review.
Stefaniuk P; Szymczyk A; Podhorecka M
Cancer Manag Res; 2020; 12():2961-2977. PubMed ID: 32425606
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis.
Lee SF; Ng TY; Spika D
BMC Cancer; 2019 Apr; 19(1):338. PubMed ID: 30971203
[TBL] [Abstract][Full Text] [Related]
6. [Tumor-associated macrophages: Function and differentiation].
Niedobitek G; Barros MH; Dreyer JH; Hauck F; Al-Sheikhyaqoob D
Pathologe; 2015 Sep; 36(5):477-84. PubMed ID: 26280511
[TBL] [Abstract][Full Text] [Related]
7. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
[TBL] [Abstract][Full Text] [Related]
9. Interim PET in lymphoma: a step towards standardization.
Meignan M
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1821-3. PubMed ID: 20652564
[No Abstract] [Full Text] [Related]
10. The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling.
Scott DW; Steidl C
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):144-50. PubMed ID: 25696847
[TBL] [Abstract][Full Text] [Related]
11. The genetics of Hodgkin lymphoma: an overview and clinical implications.
Borchmann S; Engert A
Curr Opin Oncol; 2017 Sep; 29(5):307-314. PubMed ID: 28697001
[TBL] [Abstract][Full Text] [Related]
12. Hematology. Are macrophages the bad guys in Hodgkin lymphoma?
Diehl V
Nat Rev Clin Oncol; 2010 Jun; 7(6):301-2. PubMed ID: 20517336
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
Steidl C; Lee T; Shah SP; Farinha P; Han G; Nayar T; Delaney A; Jones SJ; Iqbal J; Weisenburger DD; Bast MA; Rosenwald A; Muller-Hermelink HK; Rimsza LM; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Jaffe ES; Lenz G; Connors JM; Staudt LM; Chan WC; Gascoyne RD
N Engl J Med; 2010 Mar; 362(10):875-85. PubMed ID: 20220182
[TBL] [Abstract][Full Text] [Related]
14. Hematology: Treatment strategies for pediatric Hodgkin lymphoma.
Sandlund JT; Hudson MM
Nat Rev Clin Oncol; 2010 May; 7(5):243-4. PubMed ID: 20428217
[No Abstract] [Full Text] [Related]
15. Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma.
Casulo C; Arcila M; Bohn OL; Teruya-Feldstein J; Maragulia J; Moskowitz CH
Leuk Res; 2013 Sep; 37(9):1178-83. PubMed ID: 23706570
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
